Nederlandse Coöperatieve Studie naar de Adequaatheid van Dialyse

Artikelen Necosad Studiegroep


  1. Merkus, M. P., Jager, K. J., Dekker, F. W., Boeschoten, E. W., Stevens, P., and Krediet, R. T. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am.J.Kidney Dis. 29(4), 584-592. 1997.
  2. Jager, K. J., Merkus, M. P., Dekker, F. W., Boeschoten, E. W., Tijssen, J. G., Stevens, P., Bos, W. J., and Krediet, R. T. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int. 55(4), 1476-1485. 1999.
  3. Jager, K. J., Merkus, M. P., Boeschoten, E. W., Dekker, F. W., Stevens, P., and Krediet, R. T. Dialysis in The Netherlands: the clinical condition of new patients put into a European perspective. NECOSAD Study Group. Netherlands Cooperative Study on the Adequacy of Dialysis phase 1. Nephrol.Dial.Transplant. 14(10), 2438-2444. 1999.
  4. Korevaar, J. C., Jansen, M. A., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis. Adv.Perit.Dial. 15, 132-137. 1999.
  5. Merkus, M. P., Jager, K. J., Dekker, F. W., de Haan, R. J., Boeschoten, E. W., and Krediet, R. T. Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int. 56(2), 720-728. 1999.
  6. Merkus, M. P., Jager, K. J., Dekker, F. W., de Haan, R. J., Boeschoten, E. W., and Krediet, R. T. Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol.Dial.Transplant. 14(5), 1163-1170. 1999.
  7. Visser, R., Dekker, F. W., Boeschoten, E. W., Stevens, P., and Krediet, R. T. Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv.Perit.Dial. 15, 222-225. 1999.
  8. Korevaar, J. C., Jansen, M. A., Merkus, M. P., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. The NECOSAD Study Group. Perit.Dial.Int. 20(1), 69-75. 2000.
  9. Merkus, M. P., Jager, K. J., Dekker, F. W., de Haan, R. J., Boeschoten, E. W., and Krediet, R. T. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am.J.Kidney Dis. 35(1), 69-79. 2000.
  10. Ring, T., Merkus, M. P., and Krediet, R. T. Physical symptoms and quality of life in patients on chronic dialysis: results of the netherlands cooperative study on adequacy of dialysis (NECOSAD). Nephrol.Dial.Transplant. 15(2), 280-281. 2000.
  11. Jager, K. J., Merkus, M. P., Huisman, R. M., Boeschoten, E. W., Dekker, F. W., Korevaar, J. C., Tijssen, J. G., and Krediet, R. T. Nutritional status over time in hemodialysis and peritoneal dialysis. J.Am.Soc.Nephrol. 12(6), 1272-1279. 2001.
  12. Jager, K. J., Merkus, M. P., Boeschoten, E. W., Dekker, F. W., Tijssen, J. G., and Krediet, R. T. What happens to patients starting dialysis in the Netherlands? Neth.J.Med. 58(4), 163-173. 2001.
  13. Jansen, M. A., Korevaar, J. C., Dekker, F. W., Jager, K. J., Boeschoten, E. W., and Krediet, R. T. The relationship between Kt/V(urea) and nPNA in anuric peritoneal dialysis patients: a comparison with predialysis patients. Perit.Dial.Int. 21(5), 509-515. 2001.
  14. Jansen, M. A., Korevaar, J. C., Dekker, F. W., Jager, K. J., Boeschoten, E. W., and Krediet, R. T. Renal function and nutritional status at the start of chronic dialysis treatment. J.Am.Soc.Nephrol. 12(1), 157-163. 2001.
  15. Korevaar, J. C., Jansen, M. A., Dekker, F. W., Jager, K. J., Boeschoten, E. W., Krediet, R. T., and Bossuyt, P. M. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet 358(9287), 1046-1050. 29-9-2001.
  16. van Manen, J. G., Korevaar, J. C., Dekker, F. W., Reuselaars, M. C., Boeschoten, E. W., and Krediet, R. T. Changes in employment status in end-stage renal disease patients during their first year of dialysis. Perit.Dial.Int. 21(6), 595-601. 2001.
  17. Jansen, M. A., Hart, A. A., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 62(3), 1046-1053. 2002.
  18. Korevaar, J. C., Merkus, M. P., Jansen, M. A., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual.Life Res. 11(5), 437-447. 2002.
  19. Korevaar, J. C., Jansen, M. A., Dekker, F. W., Boeschoten, E. W., Bossuyt, P. M., and Krediet, R. T. Evaluation of DOQI guidelines: early start of dialysis treatment is not associated with better health-related quality of life. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am.J.Kidney Dis. 39(1), 108-115. 2002.
  20. Lameire, N., Biesen, W. V., and Vanholder, R. Initiation of dialysis--is the problem solved by NECOSAD? Nephrol.Dial.Transplant. 17(9), 1550-1552. 2002.
  21. Laudanski, K. and Nowak, Z. [Quality of life in dialysed patients--methodological issues]. Pol.Merkur Lekarski. 13(77), 421-423. 2002.
  22. van Manen, J. G., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., Bossuyt, P. M., and Krediet, R. T. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am.J.Kidney Dis. 40(1), 82-89. 2002.
  23. Groothoff, J. W., Grootenhuis, M. A., Offringa, M., Gruppen, M. P., Korevaar, J. C., and Heymans, H. S. Quality of life in adults with end-stage renal disease since childhood is only partially impaired. Nephrol.Dial.Transplant. 18(2), 310-317. 2003.
  24. Korevaar, J., van Manen, J. G., Boeschoten, E. W., Dekker, F. W., and Krediet, R. T. Evaluation of guidelines for peritoneal dialysis patients: a review from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD). Contrib.Nephrol. (140), 142-150. 2003.
  25. Korevaar, J. C., Feith, G. W., Dekker, F. W., van Manen, J. G., Boeschoten, E. W., Bossuyt, P. M., and Krediet, R. T. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 64(6), 2222-2228. 2003.
  26. Korevaar, J. C., Dekker, F. W., and Krediet, R. T. Initiation of dialysis: is the problem solved by NECOSAD? Nephrol.Dial.Transplant. 18(6), 1228-1229. 2003.
  27. Termorshuizen, F., Korevaar, J. C., Dekker, F. W., van Manen, J. G., Boeschoten, E. W., and Krediet, R. T. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2. Am.J.Kidney Dis. 41(6), 1293-1302. 2003.
  28. Termorshuizen, F., Korevaar, J. C., Dekker, F. W., Jager, K. J., van Manen, J. G., Boeschoten, E. W., and Krediet, R. T. Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands. Nephrol.Dial.Transplant. 18(3), 552-558. 2003.
  29. Termorshuizen, F., Korevaar, J. C., Dekker, F. W., van Manen, J. G., Boeschoten, E. W., and Krediet, R. T. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J.Am.Soc.Nephrol. 14(11), 2851-2860. 2003.
  30. van Manen, J. G., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., Bossuyt, P. M., and Krediet, R. T. Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use? J.Am.Soc.Nephrol. 14(2), 478-485. 2003.
  31. Jager, K. J., Korevaar, J. C., Dekker, F. W., Krediet, R. T., and Boeschoten, E. W. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am.J.Kidney Dis. 43(5), 891-899. 2004.
  32. Korevaar, J. C., van Manen, J. G., Dekker, F. W., de Waart, D. R., Boeschoten, E. W., and Krediet, R. T. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J.Am.Soc.Nephrol. 15(11), 2916-2922. 2004.
  33. Termorshuizen, F., Dekker, F. W., van Manen, J. G., Korevaar, J. C., Boeschoten, E. W., and Krediet, R. T. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J.Am.Soc.Nephrol. 15(4), 1061-1070. 2004.
  34. Jansen, M. A., Termorshuizen, F., Korevaar, J. C., Dekker, F. W., Boeschoten, E., and Krediet, R. T. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int. 68(3), 1199-1205. 2005.
  35. Kharagjitsingh, A. V., Korevaar, J. C., Vandenbroucke, J. P., Boeschoten, E. W., Krediet, R. T., Daha, M. R., and Dekker, F. W. Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients. Kidney Int. 68(3), 1215-1222. 2005.
  36. Korevaar, J. C., van Manen, J. G., Boeschoten, E. W., Dekker, F. W., and Krediet, R. T. When to start dialysis treatment: where do we stand? Perit.Dial.Int. 25 Suppl 3, S69-S72. 2005.
  37. Noordzij, M., Korevaar, J. C., Boeschoten, E. W., Dekker, F. W., Bos, W. J., and Krediet, R. T. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am.J.Kidney Dis. 46(5), 925-932. 2005.
  38. van der Sman-de Beer, Verhagen, C., Rombach, S. M., Boorsma, P., van Manen, J. G., Korevaar, J. C., van den Bogaard, R., Boeschoten, E. W., Krediet, R. T., Navis, G. J., Vandenbroucke, J. P., and Dekker, F. W. ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. Kidney Int. 68(5), 2237-2243. 2005.
  39. den Elzen, W. P., van Manen, J. G., Boeschoten, E. W., Krediet, R. T., and Dekker, F. W. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol.Dial.Transplant. 21(6), 1588-1595. 2006.
  40. Havekes, B., van Manen, J. G., Krediet, R. T., Boeschoten, E. W., Vandenbroucke, J. P., and Dekker, F. W. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am.J.Kidney Dis. 47(5), 823-829. 2006.
  41. Noordzij, M., Korevaar, J. C., Bos, W. J., Boeschoten, E. W., Dekker, F. W., Bossuyt, P. M., and Krediet, R. T. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol.Dial.Transplant. 21(9), 2513-2520. 2006.
  42. Noordzij, M., Korevaar, J. C., Boeschoten, E. W., Dekker, F. W., Bos, W. J., and Krediet, R. T. Hyperphosphataemia and related mortality. Nephrol.Dial.Transplant. 21(9), 2676-2677. 2006.
  43. Rutten, J. H., Korevaar, J. C., Boeschoten, E. W., Dekker, F. W., Krediet, R. T., Boomsma, F., and van den Meiracker, A. H. B-type natriuretic peptide and amino-terminal atrial natriuretic peptide predict survival in peritoneal dialysis. Perit.Dial.Int. 26(5), 598-602. 2006.
  44. Burkart, J., Piraino, B., Kaldas, H., Lee, J. Y., Bender, F. H., Krediet, R. T., Boeschoten, E. W., Dekker, F. W., Vonesh, E., and Mujais, S. Why is the evidence favoring hemodialysis over peritoneal dialysis misleading? Semin.Dial. 20(3), 200-202. 2007.
  45. de, Mutsert R., Snijder, M. B., van der Sman-de Beer, Seidell, J. C., Boeschoten, E. W., Krediet, R. T., Dekker, J. M., Vandenbroucke, J. P., and Dekker, F. W. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J.Am.Soc.Nephrol. 18(3), 967-974. 2007.
  46. Grootendorst, D. C., de Jager, D. J., Brandenburg, V. M., Boeschoten, E. W., Krediet, R. T., and Dekker, F. W. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP. Nephrol.Dial.Transplant. 22(11), 3277-3284. 2007.
  47. Hermans, M. M., Brandenburg, V., Ketteler, M., Kooman, J. P., van der Sande, F. M., Boeschoten, E. W., Leunissen, K. M., Krediet, R. T., and Dekker, F. W. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int. 72(2), 202-207. 2007.
  48. Hoek, F. J., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol.Dial.Transplant. 22(6), 1633-1638. 2007.
  49. Hoek, F. J., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. Reply-Cystatin C for Estimation of Residual GFR. Nephrol.Dial.Transplant.  14-12-2007.
  50. Korevaar, J. C., Boeschoten, E. W., Dekker, F. W., and Krediet, R. T. What have we learned from NECOSAD? Practical implications for peritoneal dialysis patients. Perit.Dial.Int. 27(1), 11-15. 2007.
  51. Noordzij, M., Boeschoten, E. W., Bos, W. J., Dekker, F. W., Bossuyt, P. M., Krediet, R. T., and Korevaar, J. C. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol.Dial.Transplant. 22(10), 2944-2949. 2007.
  52. Thong, M. S., Kaptein, A. A., Krediet, R. T., Boeschoten, E. W., and Dekker, F. W. Social support predicts survival in dialysis patients. Nephrol.Dial.Transplant. 22(3), 845-850. 2007.
  53. Voormolen, N., Noordzij, M., Grootendorst, D. C., Beetz, I., Sijpkens, Y. W., van Manen, J. G., Boeschoten, E. W., Huisman, R. M., Krediet, R. T., and Dekker, F. W. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol.Dial.Transplant. 22(10), 2909-2916. 2007.
  54. de, Mutsert R., Grootendorst, D. C., Axelsson, J., Boeschoten, E. W., Krediet, R. T., and Dekker, F. W. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol.Dial.Transplant. 23(9), 2957-2964. 2008.
  55. Noordzij, M., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., Bos, W. J., Krediet, R. T., Bossuyt, P. M., and Geskus, R. B. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline. Blood Purif. 26(3), 231-237. 2008.
  56. Thong, M. S., Kaptein, A. A., Benyamini, Y., Krediet, R. T., Boeschoten, E. W., and Dekker, F. W. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am.J.Kidney Dis. 52(1), 111-117. 2008.
  57. de, Mutsert R., Grootendorst, D. C., Indemans, F., Boeschoten, E. W., Krediet, R. T., and Dekker, F. W. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J.Ren Nutr. 19(2), 127-135. 2009.
  58. de, Mutsert R., Grootendorst, D. C., Boeschoten, E. W., Brandts, H., van Manen, J. G., Krediet, R. T., and Dekker, F. W. Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. Am.J.Clin.Nutr. 89(3), 787-793. 2009.
  59. de, Mutsert R., Grootendorst, D. C., Boeschoten, E. W., Dekker, F. W., and Krediet, R. T. Is obesity associated with a survival advantage in patients starting peritoneal dialysis? Contrib.Nephrol. 163, 124-131. 2009.
  60. Drechsler, C., de, Mutsert R., Grootendorst, D. C., Boeschoten, E. W., Krediet, R. T., le, Cessie S., Wanner, C., and Dekker, F. W. Association of body mass index with decline in residual kidney function after initiation of dialysis. Am.J.Kidney Dis. 53(6), 1014-1023. 2009.
  61. Jansen, D. L., Rijken, M., Heijmans, M., and Boeschoten, E. Perceived autonomy and self-esteem in Dutch dialysis patients: The importance of illness and  treatment perceptions. Psychology & Health 25(6), 733-749. 24-4-2009.
  62. Kolesnyk, I., Noordzij, M., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol.Dial.Transplant. 24(1), 272-277. 2009.
  63. Michels, W. M., Verduijn, M., Boeschoten, E. W., Dekker, F. W., and Krediet, R. T. Similar survival on automated peritoneal dialysis and continuous ambulatory peritoneal dialysis in a large prospective cohort. Clin.J.Am.Soc.Nephrol. 4(5), 943-949. 2009.
  64. Muntinghe, F. L., Verduijn, M., Zuurman, M. W., Grootendorst, D. C., Carrero, J. J., Qureshi, A. R., Luttropp, K., Nordfors, L., Lindholm, B., Brandenburg, V., Schalling, M., Stenvinkel, P., Boeschoten, E. W., Krediet, R. T., Navis, G., and Dekker, F. W. CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J.Am.Soc.Nephrol. 20(7), 1641-1649. 2009.
  65. Noordzij, M., Voormolen, N. M., Boeschoten, E. W., Dekker, F. W., Bos, W. J., Krediet, R. T., and Korevaar, J. C. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients. Nephrol.Dial.Transplant. 24(5), 1580-1587. 2009.
  66. Thong, M. S., van, Dijk S., Noordzij, M., Boeschoten, E. W., Krediet, R. T., Dekker, F. W., and Kaptein, A. A. Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. Nephrol.Dial.Transplant. 24(1), 225-230. 2009.
  67. van, Dijk S., Scharloo, M., Kaptein, A. A., Thong, M. S., Boeschoten, E. W., Grootendorst, D. C., Krediet, R. T., Dekker, F. W., Apperloo, A. J., Bijlsma, J. A., Boekhout, M., Boer, W. H., van der Boog, P. J., Buller, H. R., van, Buren M., de Charro, F. T., Doorenbos, C. J., van den Dorpel, M. A., van, Es A., Fagel, W. J., Feith, G. W., de Fijter, C. W., Frenken, L. A., van Geelen, J. A., Gerlag, P. G., Grave, W., Gorgels, J. P., Huisman, R. M., Jager, K. J., Jie, K., Koning-Mulder, W. A., Koolen, M. I., Hovinga, T. K., Lavrijssen, A. T., Luik, A. J., van der Meulen, J., Parlevliet, K. J., Raasveld, M. H., van der Sande, F. M., Schonck, M. J., Schuurmans, M. M., Siegert, C. E., Stegeman, C. A., Stevens, P., Thijssen, J. G., Valentijn, R. M., Vastenburg, G. H., Verburgh, C. A., Vincent, H. H., and Vos, P. F. Patients' representations of their end-stage renal disease: relation with mortality. Nephrol.Dial.Transplant. 24(10), 3183-3185. 2009.
  68. Bos, W. J., van Manen, J. G., Noordzij, M., Boeschoten, E. W., Krediet, R. T., and Dekker, F. W. Is the inverse relation between blood pressure and mortality normalized in 'low-risk' dialysis patients? J.Hypertens. 28(3), 439-445. 2010.
  69. Carrero, J. J., de, Mutsert R., Axelsson, J., Dekkers, O. M., Jager, K. J., Boeschoten, E. W., Krediet, R. T., and Dekker, F. W. Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol.Dial.Transplant.  9-7-2010.
  70. de Jager, D. J., Voormolen, N., Krediet, R. T., Dekker, F. W., Boeschoten, E. W., and Grootendorst, D. C. Association between time of referral and survival in the first year of dialysis in diabetics and the elderly. Nephrol.Dial.Transplant.  16-7-2010.
  71. Drechsler, C., Grootendorst, D. C., Boeschoten, E. W., Krediet, R. T., Wanner, C., and Dekker, F. W. Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patients. Nephrol.Dial.Transplant.  14-9-2010.
  72. Drechsler, C., Verduijn, M., Pilz, S., Dekker, F. W., Krediet, R. T., Ritz, E., Wanner, C., Boeschoten, E. W., and Brandenburg, V. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol.Dial.Transplant.  14-10-2010.
  73. Kolesnyk, I., Dekker, F. W., Boeschoten, E. W., and Krediet, R. T. Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit.Dial.Int. 30(2), 170-177. 2010.
  74. Meuwese, C. L., Snaedal, S., Halbesma, N., Stenvinkel, P., Dekker, F. W., Qureshi, A. R., Barany, P., Heimburger, O., Lindholm, B., Krediet, R. T., Boeschoten, E. W., and Carrero, J. J. Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-{alpha} are similarly associated with survival in haemodialysis patients. Nephrol.Dial.Transplant.  15-9-2010.
  75. Meuwese, C. L., Halbesma, N., Stenvinkel, P., Dekker, F. W., Molanaei, H., Qureshi, A. R., Barany, P., Heimburger, O., Lindholm, B., Krediet, R. T., Boeschoten, E. W., and Carrero, J. J. Variations in C-reactive protein during a single haemodialysis session do not associate with mortality. Nephrol.Dial.Transplant. 25(11), 3717-3723. 2010.
  76. Noordzij, M., Cranenburg, E. M., Engelsman, L. F., Hermans, M. M., Boeschoten, E. W., Brandenburg, V. M., Bos, W. J., Kooman, J. P., Dekker, F. W., Ketteler, M., Schurgers, L. J., Krediet, R. T., and Korevaar, J. C. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol.Dial.Transplant.  29-9-2010.
  77. Timmers, L., Thong, M. S., Dekker, F. W., Boeschoten, E., Heijmans, M., Rijken, M., Weinman, J., and Kaptein, A. A. Illness perceptions in dialysis patients and their association with quality of life.  2010.
  78. van der Wal, W. M., Noordzij, M., Dekker, F. W., Boeschoten, E., Krediet, R. T., Korevaar, J. C., and Geskus, R. B. Comparing Mortality in Renal Patients on Hemodialysis versus Peritoneal Dialysis Using a Marginal Structural Model. The International Journal of Biostatistics 6(1). 1-1-2010.
  79. Verduijn, M., Prein, R. A., Stenvinkel, P., Carrero, J. J., le, Cessie S., Witasp, A., Nordfors, L., Krediet, R. T., Boeschoten, E. W., and Dekker, F. W. Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach. Nephrol.Dial.Transplant.  5-7-2010.

  Permanent link Permanent link  |  Print this page Print this page  |  E-mail this page E-mail this page